Hyperpolarized 13C MRI

A Recap of the 2022 UCSF HMTRC Workshop

A recap of the 2022 Hyperpolarized Carbon-13 MRI Technology Development Workshop hosted by the NIH-funded UCSF Hyperpolarized MRI Technology Resource Center (HMTRC) which took place at Genentech Hall, UCSF Medical Center at Mission Bay on March 17 and 18, 2022.

National Kidney Month 2022: A Conversation with Jane Wang, MD and Peder Larson, PhD

March is National Kidney Month, a time to raise awareness and focus on research and building paths for better kidney care. Here at UCSF Radiology, we’d also like to highlight innovative research that will clinically translate to better kidney care. 

UCSF Radiology and Radiation Oncology Researchers Join Forces to Study HP 13C MRI in Prostate Cancer Undergoing Radiation Therapy

Two UCSF Radiology faculty recently received funding from National Institutes of Health (NIH)/National Cancer Institute (NCI) for an exciting research project to study hyperpolarized (HP) carbon-13 (13C) metabolic MRI in prostate cancer patients undergoing radiation therapy (RT).

An MD/PhD Collaboration to Apply Hyperpolarized 13 C Metabolic MRI for Assessing Renal Tumor Aggressiveness in Patients

Jane Wang, MD and Peder Larson, PhD are collaborating on a project applying hyperpolarized (HP) carbon 13 (13C) metabolic MRI in patients with renal tumors.

Collaborative Work Develops a Variable Resolution Approach for Improved HP 13-C MRI Acquisition

Recently, a team of scientists from UCSF Radiology, the UC Berkeley-UCSF Graduate Program in Bioengineering and the UCSF Department of Medicine Division of Cardiology came together to work to improve tradeoffs between a fixed spatial resolution and signal-to-noise ratio (SNR) for hyperpolarized 13 C MRI.

Using Hyperpolarized 13C MRI for Brain Imaging

Myriam Chaumeil PhD's lab is working to develop better and faster ways to image the brain and the way it works using hyperpolarized carbon-13 MR imaging technology.

Two Important Advances in HP 13C MRI from the UCSF HMTRC

There have been numerous studies to date that have shown the outstanding research and potential clinical value of hyperpolarized carbon-13 MR (HP 13C MRI). However, it requires major technological development to realize its full potential. Here are two recent advances from teh UCSF Hyperpolarized MRI Technology Resource Center (HMTRC). 

Hyperpolarized 13C MRI as an Emerging Molecular Imaging Technique

Hyperpolarized (HP) carbon 13 (13C) MRI is an emerging molecular imaging technique that is actively undergoing clinical translation at multiple institutions. At UCSF Radiology, we are engaged in work to develop this new technology.

Using Advanced MRI to Detect and Accurately Target Disease

In this video, Dr. Vigneron describes his work and how it’s helping tens of thousands of patients with prostate cancer and brain tumors by more accurately identifying the location of cancers, monitoring whether those cancers are responding to treatment, and, as needed, adjusting the treatment to more specifically target the disease.

Targeting and Measuring with Hyperpolarized MRI

Hyperpolarized MRI allows us to pinpoint cancers that could not be detected very well anatomically, and monitor their rate of progression. We can also learn if therapies have hit their target and measure quantitatively whether they did what was intended.